S 1115
115th Congress
Senate
Health
Administrative remedies
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Prescription drugs
Making Pharmaceutical Markets More Competitive Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 11, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 11, 2017
Introduced in Senate
Plain-English summary
Making Pharmaceutical Markets More Competitive Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to prioritize the review of generic drug applications and supplements with respect to drugs that are in a shortage or for which there are not more than three approved drugs.
The holder of an approved drug application must notify the FDA within 180 days of withdrawing or transferring the application or withdrawing the drug from sale.
The FDA must maintain a list of generic drugs with three or fewer holders of approved applications.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1
Cosponsors
1